светилище ушити нечестен chan carter 2010 nature reviews immunol 10 301 Някой ден да играя неформален
mRNA as novel technology for passive immunotherapy | SpringerLink
PDF) Therapeutic antibodies for autoimmunity and inflammation
Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning | Nature Reviews Immunology
Preferential Presentation of High-Affinity Immune Complexes in Germinal Centers Can Explain How Passive Immunization Improves the Humoral Response - ScienceDirect
Frontiers | Modulation of Signaling Mediated by TSLP and IL-7 in Inflammation, Autoimmune Diseases, and Cancer | Immunology
Cancer systems immunology | eLife
Frontiers | Proteoform-Resolved FcɤRIIIa Binding Assay for Fab Glycosylated Monoclonal Antibodies Achieved by Affinity Chromatography Mass Spectrometry of Fc Moieties | Chemistry
PDF) Cancer systems immunology
Therapeutic antibodies for autoimmunity and inflammation | Nature Reviews Immunology
Preferential Presentation of High-Affinity Immune Complexes in Germinal Centers Can Explain How Passive Immunization Improves the Humoral Response - ScienceDirect
Targeting cytokines in disease | Nature Immunology
Cancer systems immunology | eLife
Frontiers | Factors Affecting Early Antibody Secreting Cell Maturation Into Long-Lived Plasma Cells | Immunology
mRNA as novel technology for passive immunotherapy | SpringerLink
Therapeutic antibodies for autoimmunity and inflammation | Nature Reviews Immunology
Cancer systems immunology | eLife
Advances in targeting cell surface signalling molecules for immune modulation | Nature Reviews Drug Discovery
Microfluidic single-cell technology in immunology and antibody screening - ScienceDirect
Frontiers | Mass Cytometry Imaging for the Study of Human Diseases—Applications and Data Analysis Strategies | Immunology
Therapeutic antibodies for autoimmunity and inflammation | Nature Reviews Immunology
Frontiers | Plasticity in Pro- and Anti-tumor Activity of Neutrophils: Shifting the Balance | Immunology
Microfluidic single-cell technology in immunology and antibody screening - ScienceDirect
mRNA as novel technology for passive immunotherapy | SpringerLink